Alzheimer's Disease Expert Lab (adel), Inc.

This is the first study in people for a new drug called ADEL-Y01, which is designed to target a harmful protein in the brain linked to Alzheimer's disease. The study will first test single and multiple doses in healthy volunteers to check for safety, and then test multiple doses …